Abits
ABTS
Bakkt Holdings
BKKT
Riot Platforms
RIOT
Canaan
CAN
CATHEDRA BITCOIN INC
CBTTF
US Stock MarketDetailed Quotes
RNA Avidity Biosciences
- 32.490
- -1.270-3.76%
Close Dec 13 16:00 ET
- 32.000
- -0.490-1.51%
Post 17:47 ET
3.88BMarket Cap-11.28P/E (TTM)
34.780High32.070Low1.57MVolume33.610Open33.760Pre Close51.53MTurnover1.70%Turnover RatioLossP/E (Static)119.31MShares56.00052wk High2.58P/B3.00BFloat Cap8.37052wk Low--Dividend TTM92.43MShs Float56.000Historical High--Div YieldTTM8.03%Amplitude4.825Historical Low32.723Avg Price1Lot Size
About Avidity Biosciences Company
Avidity Biosciences, Inc. engages in the development of a new class of oligonucleotide-based therapies called Antibody Oligonucleotide Conjugates (AOC). It utilizes its AOC platform to design, engineer, and develop therapeutics that combine the tissue selectivity of monoclonal antibodies and the precision of oligonucleotide-based therapies in order to access previously undruggable tissue and cell types and more effectively target underlying genetic drivers of diseases. The company was founded by Troy E. Wilson, Kent Hawryluk, Mark E. Davis, and Francis Patrick McCormick on November 13, 2012 and is headquartered in San Diego, CA.
Company Profile
SymbolRNA
Company NameAvidity Biosciences
Listing DateJun 12, 2020
Issue Price18.00
Founded2012
CEOMs. Sarah Boyce
MarketNASDAQ
Employees253
Fiscal Year Ends12-31
Address10578 Science Center Drive,Suite 125
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92121
Phone1-858-401-7900
Company Executives
- Name
- Position
- Salary
- Sarah Boyce
- Director, President and Chief Executive Officer
- 11.14M
- Teresa McCarthy
- Chief Human Resources Officer
- 3.73M
- Michael F. Maclean
- Chief Financial Officer, Chief Business Officer and Principal Accounting Officer
- 4.48M
- Eric Mosbrooker
- Chief Strategy Officer
- 235.31K
- Dr. W. Michael Flanagan
- Chief Scientific and Technical Officer
- 4.89M
- Dr. Troy E. Wilson, PhD, J.D.
- Chairman of the Board
- 260.31K
- Dr. Arthur A. Levin,PhD
- Distinguished Scientist and Strategic Leader and Director
- 3.03M
- Tamar Thompson
- Independent Director
- 239.31K
- Simona Skerjanec, M.B.A.
- Independent Director
- --
- Dr. Noreen Roth Henig, M.D.
- Independent Director
- 245.81K
- Jean Kim
- Independent Director
- 237.81K
- Carsten Boess
- Independent Director
- 245.31K
- Dr. Edward M. Kaye, M.D.
- Independent Director
- 244.31K
Trending US Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.